supply of - rituximab 500 mg inj , beclomethasone dipropionate 50 mcg per dose metered aerosol 200 dose unit inh , salmeterol 25 mcg salmeterol fluticasone 250 mcg 134 aqs 07 p 9120 mdi conuter , formeterol 6mcg plus tiotropium 9mcg mdi , beclomethasone diproprionate 50 mcg levosalbutamol 50mcg inhaler 200 dose units , formoterol 6 mcg glycopyrronium 25 mcg dry powder inhaler , rotahaler , rotacap formeterol 6 mcg plus glycopyrronium 25 mcg , ursodeoxycholic acid 300 mg tab , alfuzosin 10 mg cap

Indian Army has invited bids for the supply of - rituximab 500 mg inj , beclomethasone dipropionate 50 mcg per dose metered aerosol 200 dose unit inh , salmeterol 25 mcg salmeterol fluticasone 250 mcg 134 aqs 07 p 9120 mdi conuter , formeterol 6mcg plus tiotropium 9mcg mdi , beclomethasone diproprionate 50 mcg levosalbutamol 50mcg inhaler 200 dose units , formoterol 6 mcg glycopyrronium 25 mcg dry powder inhaler , rotahaler , rotacap formeterol 6 mcg plus glycopyrronium 25 mcg , ursodeoxycholic acid 300 mg tab , alfuzosin 10 mg cap tab , micronised purified flavonoid fraction 1000 mg , tolterodine tartrate 2 mg tab , drotaverin hcl 40mg tab , midodrine 2 point 5mg tab , rosuvastatin 10mg tab , etoricoxib 60mg tab , evening primrose oil 500 mg , faropenem 300 mg tab , rivaroxaban 15 mg tab , buprenorphine patch 10 mcg , alprazolam 0 point 25 mg tab , chlorpromazine 25mg tab , aripiprazole 10 mg tab , sertraline 50 mg tab , risperidone 0 point 5 mg tab , tab valacyclovir hcl 500 mg , abrocitinib tab 100mg , rifampicin 450mg cap , tab trimethoprim plus sulphamethoxazole 160 plus 800 cotrimoxazole ds , sofosbuvir 400mg tab , tab atorvasation 10 mg plus fenofibrate 160 mg , sacchaomyces boullardi 250 mg cap , s adenosyl methionine 400mg tab , rituximab 100mg inj - re 100 rituximab inj and 33 more | quantity - 610934. The estimated project cost is ₹0.37 Cr. Please refer to the tender document for EMD details. Interested bidders can submit applications until 6 October 2026, with the technical opening scheduled for 6 October 2026.